Literature DB >> 27903330

Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention.

Rebecca L Koscik1, Sara E Berman2, Lindsay R Clark1, Kimberly D Mueller1, Ozioma C Okonkwo1, Carey E Gleason3, Bruce P Hermann1, Mark A Sager1, Sterling C Johnson3.   

Abstract

OBJECTIVES: Intraindividual cognitive variability (IICV) has been shown to differentiate between groups with normal cognition, mild cognitive impairment (MCI), and dementia. This study examined whether baseline IICV predicted subsequent mild to moderate cognitive impairment in a cognitively normal baseline sample.
METHODS: Participants with 4 waves of cognitive assessment were drawn from the Wisconsin Registry for Alzheimer's Prevention (WRAP; n=684; 53.6(6.6) baseline age; 9.1(1.0) years follow-up; 70% female; 74.6% parental history of Alzheimer's disease). The primary outcome was Wave 4 cognitive status ("cognitively normal" vs. "impaired") determined by consensus conference; "impaired" included early MCI (n=109), clinical MCI (n=11), or dementia (n=1). Primary predictors included two IICV variables, each based on the standard deviation of a set of scores: "6 Factor IICV" and "4 Test IICV". Each IICV variable was tested in a series of logistic regression models to determine whether IICV predicted cognitive status. In exploratory analyses, distribution-based cutoffs incorporating memory, executive function, and IICV patterns were used to create and test an MCI risk variable.
RESULTS: Results were similar for the IICV variables: higher IICV was associated with greater risk of subsequent impairment after covariate adjustment. After adjusting for memory and executive functioning scores contributing to IICV, IICV was not significant. The MCI risk variable also predicted risk of impairment.
CONCLUSIONS: While IICV in middle-age predicts subsequent impairment, it is a weaker risk indicator than the memory and executive function scores contributing to its calculation. Exploratory analyses suggest potential to incorporate IICV patterns into risk assessment in clinical settings. (JINS, 2016, 22, 1016-1025).

Entities:  

Keywords:  Alzheimer’s disease; Mild cognitive impairment; Neuropsychological tests; Prodromal period; Psychometrics; Risk screening

Mesh:

Year:  2016        PMID: 27903330      PMCID: PMC5147731          DOI: 10.1017/S135561771600093X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  23 in total

Review 1.  Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Authors:  Paul S Aisen; Ronald C Petersen; Michael C Donohue; Anthony Gamst; Rema Raman; Ronald G Thomas; Sarah Walter; John Q Trojanowski; Leslie M Shaw; Laurel A Beckett; Clifford R Jack; William Jagust; Arthur W Toga; Andrew J Saykin; John C Morris; Robert C Green; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 3.  Future directions in Alzheimer's disease from risk factors to prevention.

Authors:  Bushra Imtiaz; Anna-Maija Tolppanen; Miia Kivipelto; Hilkka Soininen
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

4.  Heterogeneous ability profiles may be a unique indicator of impending cognitive decline.

Authors:  Timothy A Salthouse; Andrea Soubelet
Journal:  Neuropsychology       Date:  2014-05-05       Impact factor: 3.295

5.  AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.

Authors:  Frank Jessen; Steffen Wolfsgruber; Birgitt Wiese; Horst Bickel; Edelgard Mösch; Hanna Kaduszkiewicz; Michael Pentzek; Steffi G Riedel-Heller; Tobias Luck; Angela Fuchs; Siegfried Weyerer; Jochen Werle; Hendrik van den Bussche; Martin Scherer; Wolfgang Maier; Michael Wagner
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

6.  Within-person across-neuropsychological test variability and incident dementia.

Authors:  Roee Holtzer; Joe Verghese; Cuiling Wang; Charles B Hall; Richard B Lipton
Journal:  JAMA       Date:  2008-08-20       Impact factor: 56.272

7.  Intraindividual variability across cognitive domains: investigation of dispersion levels and performance profiles in older adults.

Authors:  Jennifer V Hilborn; Esther Strauss; David F Hultsch; Michael A Hunter
Journal:  J Clin Exp Neuropsychol       Date:  2009-05       Impact factor: 2.475

Review 8.  Preclinical Alzheimer disease-the challenges ahead.

Authors:  Reisa A Sperling; Jason Karlawish; Keith A Johnson
Journal:  Nat Rev Neurol       Date:  2012-11-27       Impact factor: 42.937

9.  Intraindividual variability in domain-specific cognition and risk of mild cognitive impairment and dementia.

Authors:  Leslie Vaughan; Iris Leng; Dale Dagenbach; Susan M Resnick; Stephen R Rapp; Janine M Jennings; Robert L Brunner; Sean L Simpson; Daniel P Beavers; Laura H Coker; Sarah A Gaussoin; Kaycee M Sink; Mark A Espeland
Journal:  Curr Gerontol Geriatr Res       Date:  2013-12-22

10.  Intraindividual variability across cognitive tasks as a potential marker for prodromal Alzheimer's disease.

Authors:  Andrea M Kälin; Marlon Pflüger; Anton F Gietl; Florian Riese; Lutz Jäncke; Roger M Nitsch; Christoph Hock
Journal:  Front Aging Neurosci       Date:  2014-07-04       Impact factor: 5.750

View more
  18 in total

1.  Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.

Authors:  Katherine J Bangen; Alexandra J Weigand; Kelsey R Thomas; Lisa Delano-Wood; Lindsay R Clark; Joel Eppig; Madeleine L Werhane; Emily C Edmonds; Mark W Bondi
Journal:  Neuropsychology       Date:  2019-03-21       Impact factor: 3.295

2.  Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.

Authors:  Carey E Gleason; Derek Norton; Eric D Anderson; Michelle Wahoske; Danielle T Washington; Emre Umucu; Rebecca L Koscik; N Maritza Dowling; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  The recency ratio as predictor of early MCI.

Authors:  Davide Bruno; Rebecca L Koscik; John L Woodard; Nunzio Pomara; Sterling C Johnson
Journal:  Int Psychogeriatr       Date:  2018-04-18       Impact factor: 3.878

4.  Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study.

Authors:  Rebecca L Koscik; Derek L Norton; Samantha L Allison; Erin M Jonaitis; Lindsay R Clark; Kimberly D Mueller; Bruce P Hermann; Corinne D Engelman; Carey E Gleason; Mark A Sager; Richard J Chappell; Sterling C Johnson
Journal:  J Int Neuropsychol Soc       Date:  2018-12-07       Impact factor: 2.892

5.  Predicting Early Mild Cognitive Impairment With Free Recall: The Primacy of Primacy.

Authors:  Deborah Talamonti; Rebecca Koscik; Sterling Johnson; Davide Bruno
Journal:  Arch Clin Neuropsychol       Date:  2020-02-20       Impact factor: 2.813

6.  Relationship of Cognitive and Social Engagement to Health and Psychological Outcomes in Community-Dwelling Older Adults.

Authors:  Daniel Liebzeit; Wan-Chin Kuo; Beverly Carlson; Kimberly Mueller; Rebecca L Koscik; Marianne Smith; Sterling Johnson; Lisa Bratzke
Journal:  Nurs Res       Date:  2022-03-04       Impact factor: 2.364

7.  Preliminary assessment of connected speech and language as marker for cognitive change in late middle-aged Black/African American adults at risk for Alzheimer's disease.

Authors:  Elizabeth Evans; Sheryl L Coley; Diane C Gooding; Nia Norris; Celena M Ramsey; Gina Green-Harris; Kimberly D Mueller
Journal:  Aphasiology       Date:  2021-06-18       Impact factor: 1.902

8.  Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.

Authors:  Kimberly D Mueller; Rebecca L Koscik; Lianlian Du; Davide Bruno; Erin M Jonaitis; Audra Z Koscik; Bradley T Christian; Tobey J Betthauser; Nathaniel A Chin; Bruce P Hermann; Sterling C Johnson
Journal:  Cortex       Date:  2020-07-31       Impact factor: 4.027

9.  The Latent Structure and Test-Retest Stability of Connected Language Measures in the Wisconsin Registry for Alzheimer's Prevention (WRAP).

Authors:  Kimberly D Mueller; Rebecca L Koscik; Lindsay R Clark; Bruce P Hermann; Sterling C Johnson; Lyn S Turkstra
Journal:  Arch Clin Neuropsychol       Date:  2018-12-01       Impact factor: 2.813

10.  Serial position effects in the Logical Memory Test: Loss of primacy predicts amyloid positivity.

Authors:  Davide Bruno; Kimberly D Mueller; Tobey Betthauser; Nathaniel Chin; Corinne D Engelman; Bradley Christian; Rebecca L Koscik; Sterling C Johnson
Journal:  J Neuropsychol       Date:  2020-12-04       Impact factor: 2.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.